Trends in Metabolic and Bariatric Surgery Use During the GLP-1 Receptor Agonist Era

JAMA Surgery 2026 Open access

Read full text
Authors: Stefanie Rohde, Grace F. Chao, Mahmoud Abdel‐Rasoul, Mohamed I. Elsaid, Patrick Sweigert
DOI: 10.1001/jamasurg.2026.0049
Cited by: 9
References: 3

Abstract

This cross-sectional analysis examines trends through 2025 in the use of metabolic and bariatric surgery during a period of increasing use of glucagon-like peptide-1 (GLP-1) receptor agonists.

Fields of Study & Subjects

Bariatric Surgery and Outcomes Diabetes Treatment and Management Hyperglycemia and glycemic control in critically ill and hospitalized patients

Publication details

Journal / source
JAMA Surgery
Publisher
American Medical Association (AMA)
Volume
161
Issue
5
Pages
546–546
Publication date
4 March 2026
Language
EN